LEADER 01602nam--2200409---450 001 990001902340203316 005 20221020085051.0 035 $a000190234 035 $aUSA01000190234 035 $a(ALEPH)000190234USA01 035 $a000190234 100 $a20040803d19------km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $aa|||||||001yy 200 1 $aCatalogo della scrittura femminile italiana a stampa presente nei fondi librari della Biblioteca nazionale di Napoli$fdi Anna Santoro, Francesca Veglione 210 $aNapoli$cAmministrazione provinciale di Napoli$d19- 215 $avolumi$d21x30 cm 225 2 $aScrittura donna 327 1 $a1. : Dalle origini al 1860 / a cura e con prefazione di Anna Santoro. - [s.d.]. - 212 p. : ill. -2.: Dalle origini della stampa al 1900 /a cura e con prefazione di Anna Santoro. - 1990. - XVII, 116 p.: ill., [2] carte di tav., [1] carta ripiegata 410 0$12001$aScrittura donna 517 $aDalle origini al 1860 606 0 $aScrittrici italiane$xOpere$ySec. 16.-20. 607 $aBiblioteca Nazionale$xCataloghi 676 $a013.042 700 1$aSANTORO,$bAnna$0143080 701 1$aVEGLIONE,$bFrancesca$0718288 801 0$aIT$bsalbc$gISBD 912 $a990001902340203316 951 $aI.2.C. 279/1 (016 SAN)$b9365 L.M.$c016 951 $a013.042 SAN$b1124 Crd.$c013$d00331512 959 $aBK 969 $aUMA 969 $aCRD 969 $aCAS 996 $aCatalogo della scrittura femminile italiana a stampa presente nei fondi librari della Biblioteca nazionale di Napoli$91392765 997 $aUNISA LEADER 01298nam 2200361Ia 450 001 996389514503316 005 20221108073207.0 035 $a(CKB)4940000000095726 035 $a(EEBO)2240869391 035 $a(OCoLC)82474834 035 $a(EXLCZ)994940000000095726 100 $a20070209d1624 uy 0 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe earths encrease. Or, a communion cup$b[electronic resource] $epresented to the Kings most excellent Majesty for a New-Yeeres gift. /$fBy the reuerend Father in God, the Bishop of Landaff. 210 $aPrinted at London $cby Miles Flesher, for Nath. Feild [sic].$d1624. 215 $a[16], 67 p 300 $aSignatures: A-E? F². 300 $aReproduction of original in: Massachusetts Historical Society. 320 $aIncludes bibliographical references in marginal notes. 330 $aeebo-0089 606 $aNew Year sermons$zEngland$vEarly works to 1800 606 $aSermons, English$y17th century 615 0$aNew Year sermons 615 0$aSermons, English 700 $aField$b Theophilus$f1574-1636.$01015194 801 0$bUMI 801 1$bUMI 801 2$bUMI 906 $aBOOK 912 $a996389514503316 996 $aThe earths encrease. Or, a communion cup$92401739 997 $aUNISA LEADER 03501nam 22005295 450 001 9910337509503321 005 20251113205433.0 010 $a3-030-15301-0 024 7 $a10.1007/978-3-030-15301-4 035 $a(CKB)4100000008493324 035 $a(DE-He213)978-3-030-15301-4 035 $a(MiAaPQ)EBC5799383 035 $a(PPN)242825249 035 $a(EXLCZ)994100000008493324 100 $a20190624d2019 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Screening in Inflammatory Bowel Disease $eA Guide to Risk Management and Techniques /$fedited by Joseph D. Feuerstein, Adam S. Cheifetz 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (XI, 174 p. 14 illus. in color.) 311 08$a3-030-15300-2 327 $aEpidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy. 330 $aThis book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease. 606 $aGastroenterology 606 $aColon (Anatomy)$xSurgery 606 $aOncology 606 $aGastroenterology 606 $aColorectal Surgery 606 $aOncology 615 0$aGastroenterology. 615 0$aColon (Anatomy)$xSurgery. 615 0$aOncology. 615 14$aGastroenterology. 615 24$aColorectal Surgery. 615 24$aOncology. 676 $a616.33 676 $a616.344 702 $aFeuerstein$b Joseph D$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aCheifetz$b Adam S$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910337509503321 996 $aCancer Screening in Inflammatory Bowel Disease$91736115 997 $aUNINA